EGFR and pancreatic neoplasm: One example of this phenomenon is provided by the SW1990 pancreatic cancer cell line where oncogenic EGFR signaling is dampened by 1,3,4-O-Bu3ManNAc-driven sialylation (Mathew et al., 2016).